(PHC) Plant Health Care
Summary
Trade long or short on this share now through an Interactive Investor Spread Bet or CFD
|
|
|||||||||||||||||||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||||||||||||||||||||
| Headline | Source | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
||||||||||||||||||
| 01-02-12 | RNS |
|||||||||||||||||
|
RNS Number : 5493W Plant Health Care PLC 01 February 2012 01 February 2012
Plant Health Care plc
PLANT HEALTH CARE ANNOUNCES DISTRIBUTION DEAL WITH AGRIUM SUBSIDIARY Plant Health Care (AIM: PHC), a leading provider of naturally derived products to the agriculture and horticulture industries, announces that it has signed an exclusive, multi-year agreement with ASP-Chile ("ASP"), a wholly owned subsidiary of Agrium Inc, one of North America's largest fertilizer manufacturers that supplies North and South America and Australia with all of the major agriculture nutrients. No financial details are disclosed.
Plant Health Care will supply ASP with its Myconate and Harpin products for use on all crops in Chile. Harpin will be marketed for all foliar uses while Myconate may be applied by seed treatment or ground application. Plant Health Care will work with ASP whilst it tests the products in order for them to be registered in Chile, after which the products can be available for sale, expected to begin within the next two years.
Chile is an important agricultural producer with more than six million acres under production and it is a major supplier of off-season produce to Europe and North America. ASP is one of Chile's leading providers of chemicals and specialty nutrients for agriculture. This deal marks a significant milestone in that it represents the first time in the South American market that Plant Health Care has entered into a major supply agreement in which its products are able to be used on all crops.
Myconate is a patented, synthetic compound that encourages plant growth by stimulating existing mycorrhizal fungi in the soil and creating a bigger root mass. More than six years of successful field trials provide product efficacy with increased yields, during tests, of up to 30% depending upon crop and location. Plant Health Care's aim is that that Myconate will become a standard element of farmer's seeding and nutrition programmes on a global basis.
Harpin is a patented, specific protein that activates a plant's innate ability to protect itself and, at the same time, enhances growth and yield. In addition, the technology offers an important range of post-harvest benefits such as improved fruit quality and extended shelf-life. This is an important factor in Chile which has to ship fresh produce over long distances to reach important markets.
"This is an important breakthrough in our strategy to gain global market penetration for our products" said John Brady, CEO of Plant Health Care. "ASP Chile is a major player in its local market and this relationship is a significant stepping stone towards achieving further deals in the important agricultural countries of South America.
"We are convinced that our customers will benefit from this new cooperation," said Laura Etchegorry, General Manager of ASP Chile. "This partnership with Plant Health Care is an extension of the outstanding work that PHC developed in the United States. This cooperation enables ASP Chile to continue to provide to Chilean farmers, best solutions to make their businesses more profitable, clean and efficient".
- ENDS -
For further information, please contact:
Notes to Editors
About Plant Health Care plc: Plant Health Care plc ("PHC") is a leading provider of naturally derived products for plants and soil. Established in 1995 in Pittsburgh (Pennsylvania) in the United States, PHC currently has approximately 40 employees and has operations in the United States, Mexico, the United Kingdom, Spain and the Netherlands.
The Company's ordinary shares have been quoted on the AIM Market of the London Stock Exchange since July 2004 and listed on the Official List of the Channel Islands Stock Exchange ("CISX") in February 2010 (ticker symbol/ mnemonic: PHC).
PHC's products are aimed at the agriculture and landscape industries and are environmentally beneficial. Through the commercialisation of these products, PHC is capitalising on current long-term trends toward natural systems and biological products for plant care and soil and water management. Further information is available at: www.planthealthcare.com.
Trademarks: Myconate and Harpin are trademarks or trade names which Plant Health Care owns or which others own and license to Plant Health Care for use.
About ASP Chile: ASP CHILE S.A. is one of the most important Chilean distributors of the full range of crop protection products required by our customers for efficient production of all major farm commodities in Chile. We value our relationships with our vendors, who comprise a list of the most respected basic manufacturers of crop protection products in the world.
Owned by Agrium group, ASP CHILE S.A. conducts research and training throughout the year to stay abreast of new and improved chemistry available through modern crop protection products. The ASP Chile's obligation to be familiar with the full range of products we offer so that we can provide to our customers with accurate information on their use, benefits and limitations. Further information please visit: www.asp-chile.cl and www.agrium.com" This information is provided by RNS The company news service from the London Stock Exchange More |
||||||||||||||||||
| 18-01-12 | RNS |
|||||||||||||||||
|
RNS Number : 7281V Plant Health Care PLC 18 January 2012
18 January 2012
PLANT HEALTH CARE PLC ("Plant Health Care" or "the Company")
Trading Update
Plant Health Care (AIM: PHC.L), a leading provider of naturally-derived products to the agriculture industry, provides the following post year-end update ahead of the announcement of its full year results to 31 December 2011, which are expected on 27 February 2012. All results provided are preliminary and subject to completion of the 2011 audit.
The Board is pleased to report that the operating loss before share-based payments is expected to be approximately $6.7 million, on revenues of $7.9 million. Due to tight control over operating costs, the operating loss was better than expectations, with revenues being slightly less than expectations. As a consequence of the lower losses and strong collections from debtors, the Company is expecting to report cash and cash equivalents at year-end of US$14 million, significantly ahead of expectations. The Company is focused on accelerating the development and improving performance of its core Harpin and Myconate technologies. As a result, R&D spend on next generation product development and formulations doubled in 2011, and is expected to increase at a similar rate in 2012 to over $1mm.
The Company has also been strongly focused on the pursuit of further significant partnering relationships. The following is a progress report on the most significant aspects of the business:
· On-ground sales (end-user application of the product) of Harpin in the US rose approximately 40% in 2011 from programmes driven by the Company and its partners to increase market awareness and acceptance of Harpin as a critical biological enhancement to existing seed treatment options. As a result of in-hand distributor orders, we expect 2012 on-ground sales to more than triple 2011 levels. On-ground sales of Harpin have also grown rapidly in Mexico and South Africa as a result of initiatives in those markets. Both countries experienced roughly 50% growth in on-ground sales in 2011, and we expect this to accelerate by 70% in 2012. · As a result of the success of on-ground sales, Plant Health Care is in discussions with a number of global and regional agrichemical and agricultural supply companies to further exploit its Harpin and Myconate technologies, on new crops, by new product applications and in new geographical regions. Good progress is being made towards finalising substantial new partnering agreements during 2012. · 2011 delivered the best set of trial results with Harpin and Myconate that the Company has ever experienced. The strength of these results has helped escalate our partnering discussions. · We have developed six next generation Harpin product candidates that will be moving into initial field trials in 2012. All six candidates have exhibited significantly stronger attributes in greenhouse trials than the Harpin products that are currently in the market.
The Board has been greatly encouraged by the progress made in the past 12 months and believes that the increasing use of Harpin and Myconate-based products and the pipeline of potential new partnering transactions will ensure that our present cash resources will be sufficient to fund the Company through to profitability in future periods.
John Brady, Chief Executive of Plant Health Care, said: "The sale of the US retail and landscape business at the start of 2011 has allowed us to focus on obtaining licensing agreements for Harpin and Myconate and on supporting our partners in the introduction of new products. Good progress across the business and our strong trial results mean we remain confident of substantial progress and further important developments during 2012."
-Ends- For further information please contact:
Notes to editors: About Plant Health Care plc: Plant Health Care plc ("PHC") is a leading provider of naturally derived products for plants and soil. Established in 1995 in Pittsburgh (Pennsylvania) in the United States, PHC currently has approximately 40 employees and has operations in the United States, Mexico, the United Kingdom, Spain, and the Netherlands.
The Company's ordinary shares have been quoted on the AIM Market of the London Stock Exchange since July 2004 and listed on the Official List of the Channel Islands Stock Exchange ("CISX") since February 2010 (ticker symbol/ mnemonic: PHC).
Trademarks: Myconate and Harpin are trademarks or trade names which Plant Health Care owns or which others own and license to Plant Health Care for use.
This information is provided by RNS The company news service from the London Stock Exchange More |
||||||||||||||||||
| 11-01-12 | RNS |
|||||||||||||||||
|
RNS Number : 3780V Plant Health Care PLC 11 January 2012 11 January 2012
Plant Health Care plc ("Plant Health Care" or "the Company")
Plant Health Care (AIM/ CISX: PHC), a leading provider of natural products for plants and soil, was notified on 10 January 2012 that, on the same day, Boulder River Capital Corporation and its affiliates had increased their total interest to 5,000,000 ordinary shares of 1p each in the Company ("Ordinary Shares"). This holding represents approximately 9.40% of the total issued share capital of the Company.
- ends -
For Further Information:
This information is provided by RNS The company news service from the London Stock Exchange More |
||||||||||||||||||
| 03-01-12 | RNS |
|||||||||||||||||
|
RNS Number : 9314U Plant Health Care PLC 03 January 2012 Second Price Monitoring Extension A second and final Price Monitoring Extension has been activated in this security. The closing auction call period is extended in this security for a further 5 minutes. Following the first price monitoring extension this security would still have executed more than a pre-determined percentage above or below the price of the most recent automated execution today. London Stock Exchange electronic order book users have a final opportunity to review the prices and sizes of orders entered in this security prior to the auction execution which will set today's closing price. The applicable percentage is set by reference to a security's Millennium Exchange sector. This is set out in the Sector Breakdown tab of the Parameters document at www.londonstockexchange.com/tradingservices This information is provided by RNS The company news service from the London Stock Exchange More |
||||||||||||||||||
| Result Pages: 1 | ||||
| Date/Time | Subject | Author | ||
|---|---|---|---|---|
| 19-12-11 | ||||
|
|
||||
|
|
||||
|
Plant Health Care (PHC) [36p/£19.15 million]
Hybridan's Small Cap Wrap By Hybridan | Mon, 19/12/2011 - 00:00 http://bit.ly/rQe7It |
||||
| 14-12-11 | ||||
|
|
||||
|
|
||||
|
|
||||
| 14-09-11 | ||||
|
|
||||
|
|
||||
|
aplogies, henderson are selling, gone from 20% to 16% but looks like someone else bought 1,5mln of those
|
||||
| 14-09-11 | ||||
|
|
||||
|
|
||||
|
appears so, been following PHC and PIM and note that Henderson gone to 16% now as per RNS today, things hotting up in the crop/fertiliser world
|
||||
|
|
||||
They have not been approved or issued by Interactive Investor Trading Limited.
Editor's Pick:
Markets: FTSE 100 in the black as Bank announces more QEEditor's Pick:
View from the top: Tangiers Petroleum interviewEditor's Pick:
Greece strikes bail-out agreementEditor's Pick:
Bank announces £50bn quantitative easing packageEditor's Pick:
Mixed outlook for trio of mining giantsEditor's Pick:
Glenstrata's just a silly word. Stick to big dividendsEditor's Pick:
Bulls should head for ChinaEditor's Pick:
George Godber’s AIM stock picks

